NUTANIX INC - A (NTNX)

US67059N1081 - Common Stock

58.75  -0.78 (-1.31%)

After market: 58.49 -0.26 (-0.44%)

Fundamental Rating

4

NTNX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 275 industry peers in the Software industry. NTNX may be in some trouble as it scores bad on both profitability and health. NTNX has a decent growth rate and is not valued too expensively.



3

1. Profitability

1.1 Basic Checks

In the past year NTNX was profitable.
In the past year NTNX had a positive cash flow from operations.
In the past 5 years NTNX always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: NTNX reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -2.47%, NTNX is in the better half of the industry, outperforming 62.91% of the companies in the same industry.
Industry RankSector Rank
ROA -2.47%
ROE N/A
ROIC N/A
ROA(3y)-29.77%
ROA(5y)-34.69%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 83.83%, NTNX belongs to the best of the industry, outperforming 92.00% of the companies in the same industry.
NTNX's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for NTNX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 83.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.73%
GM growth 5Y4.3%

3

2. Health

2.1 Basic Checks

NTNX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NTNX has been increased compared to 1 year ago.
The number of shares outstanding for NTNX has been increased compared to 5 years ago.
NTNX has a better debt/assets ratio than last year.

2.2 Solvency

NTNX has an Altman-Z score of 1.32. This is a bad value and indicates that NTNX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.32, NTNX perfoms like the industry average, outperforming 41.45% of the companies in the same industry.
The Debt to FCF ratio of NTNX is 3.18, which is a good value as it means it would take NTNX, 3.18 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.18, NTNX is doing good in the industry, outperforming 67.27% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.18
Altman-Z 1.32
ROIC/WACCN/A
WACC9.73%

2.3 Liquidity

A Current Ratio of 1.79 indicates that NTNX should not have too much problems paying its short term obligations.
The Current ratio of NTNX (1.79) is comparable to the rest of the industry.
NTNX has a Quick Ratio of 1.79. This is a normal value and indicates that NTNX is financially healthy and should not expect problems in meeting its short term obligations.
NTNX has a Quick ratio (1.79) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.79

6

3. Growth

3.1 Past

NTNX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1960.00%, which is quite impressive.
NTNX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.12%.
The Revenue has been growing by 10.02% on average over the past years. This is quite good.
EPS 1Y (TTM)1960%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q91.67%
Revenue 1Y (TTM)18.12%
Revenue growth 3Y12.52%
Revenue growth 5Y10.02%
Revenue growth Q2Q16.18%

3.2 Future

NTNX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.10% yearly.
NTNX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.80% yearly.
EPS Next Y98.45%
EPS Next 2Y55.56%
EPS Next 3Y49.96%
EPS Next 5Y45.1%
Revenue Next Year15.94%
Revenue Next 2Y16.29%
Revenue Next 3Y17.16%
Revenue Next 5Y16.8%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 57.04, which means the current valuation is very expensive for NTNX.
Based on the Price/Earnings ratio, NTNX is valued a bit cheaper than the industry average as 61.82% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 24.76. NTNX is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 44.14, NTNX can be considered very expensive at the moment.
NTNX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NTNX is cheaper than 60.73% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.26, NTNX is valued quite expensively.
Industry RankSector Rank
PE 57.04
Fwd PE 44.14

4.2 Price Multiples

NTNX's Enterprise Value to EBITDA ratio is in line with the industry average.
69.09% of the companies in the same industry are more expensive than NTNX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 36.5
EV/EBITDA 383.09

4.3 Compensation for Growth

NTNX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NTNX's earnings are expected to grow with 49.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y55.56%
EPS Next 3Y49.96%

0

5. Dividend

5.1 Amount

NTNX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NUTANIX INC - A

NASDAQ:NTNX (4/19/2024, 7:07:12 PM)

After market: 58.49 -0.26 (-0.44%)

58.75

-0.78 (-1.31%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap14.35B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 57.04
Fwd PE 44.14
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.58
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.47%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 83.83%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.79
Quick Ratio 1.79
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)1960%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y98.45%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)18.12%
Revenue growth 3Y12.52%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y